TheEdgeResearch
Home / Stocks / DOCS

Doximity, Inc. (DOCS)

NYSE Healthcare Medical - Healthcare Information Services
$26.11 ▼ -1.73%
Market Cap
$4.88B
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Beta
1.25
52-Wk Range
17.15-76.51
CEO
Jeffrey A. Tangney
Country
US
Currency
USD

Doximity, Inc. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in San Francisco, CA, US. The stock last traded at $26.11, down 1.73% on the session, giving a market capitalisation of $4.88B. On trailing twelve-month figures it carries a trailing P/E of 29.34, a net margin of 25.5%. Its beta of 1.25 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
29.34
Price / Sales
7.45
Price / Book
5.20
EV / EBITDA
18.95
Gross margin
88.1%
Operating margin
29.6%
Net margin
25.5%
Return on equity
Debt / equity
0.01
Current ratio
6.08
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
New York Stock Exchange
Employees
880
IPO date
2021-06-24
Headquarters
San Francisco, CA, US
About Doximity, Inc.

Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.

Comparable companies

Doximity, Inc. is most often compared with the following Healthcare names:

COOEHCEXASGHHQYICLRRVTYSOLVTEMVTRS
More research on DOCS
DOCS technical analysis DOCS TheEdge Score Compare against peers
Open full interactive analysis & DCF →